Orchid Island Capital attracts investors with a high yield but traps them with capital losses due to a declining share price, ...

The investment giant's flagship real estate fund returned 1.95% in 2024. Executives say a recovery is underway, although they ...

Capital Infra Trust IPO listed flat at ₹99, raising ₹703 crore. Subscription was 2.80 times overall, with institutional ...

The capital gains tax hike in the last budget raised concerns among investors about the potential for future increases. While ...

Dell Technologies Inc. (NYSE:DELL), with a market capitalization of $76.72 billion, finds itself at a pivotal juncture as it ...

DuPont de Nemours, Inc. (NYSE:DD), a leading player in the U.S. chemicals industry with a market capitalization of $32.4 ...

Solana price could see significant gains if XRP achieves an ambitious $20 trillion market capitalization. The investors and ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Marks, the co-founder of Oaktree Capital Management, highlighted several warning signs in a recent memo to clients that ...

What are the complications to watch for, and can any of 2024’s outcomes serve as clues for future success? Many investors had ...

Another engine of value creation for Wall Street that has been slow in recent years is the IPO market — which is also set to ...

Gland Pharma announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Pashamylaram facility at Hyderabad.